Excluding CYP1A1, FRMD4A and GF1 CpGs did not affect the association of Score-15 and Score-19 with lung cancer risk, and only the FRMD4A CpG score was associated with lung cancer risk (Table 5). Here, CYP1A1 is linked to lung carcinoma.